SYMBOL:

    Up to 100 tickers separated by a space .....Watch Pre-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
BIO-PATH HOLDINGS INC
(NQPK:BPTH Last Sale: 4.58 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (BPTH : $4.58)
$16,909 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Houston, TX Research Report Earnings Snapshot - Last 11/17/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


The Company’s initial focus is on cancer. Bio-Path’s lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers. Bio-Path’s second drug candidate, also a liposomal antisense drug, is ready for the clinic where it will be evaluated in lymphoma and solid tumors.
Historical Charts    Technical Analysis
No Historical Data available for BPTH

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common BPTH $4.58 $4.58 0 .0 $4.42 $4.64 45,412 $4.42 $4.64 3,691,857
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $16,908,705

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex